# Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects

> **NCT00658606** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 98 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** alefacept
- **PROCEDURE:** Narrow Band UVB Phototherapy

## Key facts

- **NCT ID:** NCT00658606
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2013-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00658606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00658606, "Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00658606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*